Capital expenditure decreased 81.7%
Capital expenditure changed -81.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed -81.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Shares outstanding changed +75.4% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Cash & equivalents changed +110.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current liabilities changed -29.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed +154.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed +79.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed +3429 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current ratio changed +153.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating margin changed +322682 basis points from the comparable as-filed period.
Gross margin changed -23244 basis points from the comparable as-filed period.
Revenue changed +34.9% from the comparable as-filed period.
Free-cash-flow proxy changed +17.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating cash flow changed +16.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Inventory changed -36.9% from the comparable as-filed period.
Capex / revenue changed -16309 basis points from the comparable as-filed period.
Cost of revenue changed +477.9% from the comparable as-filed period.
Operating income changed +9.2% from the comparable as-filed period.
Inventory / revenue changed -195630 basis points from the comparable as-filed period.
SBC / revenue changed -16627 basis points from the comparable as-filed period.
Research & development changed -17.5% from the comparable as-filed period.
Trade receivables changed -16.2% from the comparable as-filed period.
Free-cash-flow margin changed +350443 basis points from the comparable as-filed period.
Operating cash-flow margin changed +334134 basis points from the comparable as-filed period.
R&D / revenue changed -284200 basis points from the comparable as-filed period.
Receivables / revenue changed -4962 basis points from the comparable as-filed period.
Stock-based compensation changed +7.1% from the comparable as-filed period.
Total assets changed -0.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.